Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
15 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
14 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the press release related to the full year 2021 financial results
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the full year 2021 financial results presentation
|
Download |
|
23 Feb 2022 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
17 May 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 10 May and 16 May 2024
|
Download |
|
10 May 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 2 May and 9 May 2024
|
Download |
|
08 May 2024 |
Announcement of General Shareholders’ Meeting |
The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting
|
Download |
|
30 Apr 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 26 April and 30 April 2024
|
Download |
|
26 Apr 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 19 April and 25 April 2024
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
10 May 2018 |
Otros sobre negocio y situación financiera |
Update pivotal PRISMA-3 study of DORIA® (Risperidone ISM®)
|
Download |
|
25 Apr 2018 |
Información sobre resultados |
ROVI releases the press release related to the 2018 first quarter financial results
|
Download |
|
25 Apr 2018 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI informs about the call for the 2018 Ordinary General Shareholders Meeting
|
Download |
|
25 Apr 2018 |
Información sobre resultados |
ROVI releases the 2018 first quarter results presentation
|
Download |
|
04 Apr 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2018
|
Download |
Pages
